GENOSS Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 2004-02-25
- Employees
- 101
- Market Cap
- -
- Website
- http://www.genoss.com
Compare the Safety and Effectiveness of Genoss® DCB and SeQuent® Please NEO in Chinese Patients with Coronary ISR
Not Applicable
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Paclitaxel Coated PTCA Balloon Catheter(Genoss® DCB)Device: Paclitaxel Coated PTCA Balloon Catheter(SeQuent® Please NEO)
- First Posted Date
- 2021-02-23
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Genoss Co., Ltd.
- Target Recruit Count
- 224
- Registration Number
- NCT04767022
- Locations
- 🇨🇳
Department of Cardiology, First Affiliated Hospital of Air Force Medical University of Chinese PLA, Xi'an, Shaanxi, China
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please in Korean Patients With Coronary In-stent Restenosis
Not Applicable
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Paclitaxel Coated PTCA Balloon Catheter
- First Posted Date
- 2020-05-28
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Genoss Co., Ltd.
- Target Recruit Count
- 82
- Registration Number
- NCT04405063
© Copyright 2025. All Rights Reserved by MedPath